Abstract
The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which L-dopa shortened the manic-depressive cycle length when administered in a double-blind trial. This finding suggests a dopaminergic mechanism specifically in changing the frequency of cycling between depression and mania.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Bipolar Disorder / chemically induced*
-
Bipolar Disorder / drug therapy
-
Dose-Response Relationship, Drug
-
Double-Blind Method
-
Female
-
Humans
-
Levodopa / adverse effects*
-
Levodopa / therapeutic use
-
Methoxyhydroxyphenylglycol / urine
-
Middle Aged
Substances
-
Levodopa
-
Methoxyhydroxyphenylglycol